Table: begin end state 1 11 non-cytoplasmic 12 35 transmembrane 36 64 cytoplasmic 65 87 transmembrane 88 92 non-cytoplasmic 93 117 transmembrane 118 144 cytoplasmic 145 165 transmembrane 166 186 non-cytoplasmic 187 206 transmembrane 207 216 cytoplasmic 217 237 transmembrane 238 243 non-cytoplasmic 244 268 transmembrane 269 300 cytoplasmic 301 328 transmembrane 329 351 non-cytoplasmic 352 372 transmembrane 373 391 cytoplasmic 392 410 transmembrane 411 415 non-cytoplasmic 416 436 transmembrane 437 452 cytoplasmic
Input: >Echvi_4032 FitnessBrowser__Cola:Echvi_4032 MGQLIIDFSNWIWGWPLLYLLLGGGTLLFLYSGLIPFRGFGHAMKVVGGKYDDPNAKGDI TSFQALSSAIAATVGLGNISGVALAIGTGGPGAIFWMWVSAFVGMATKYFTCTLAIMYRG KDSSGHIQGGPMYVIEEGMGKKWRFLSVIFCVAGIMGLLAIFQANQLTDVIRVVLLKPFG LDHGTTTRWILGVSMMLLVATVILGGIQRIAAVASKLVPFMVTLYFISVLVILFRFGDEI LPSFWFILEDAFTGKAVLGGSIGAVIITGARRAAFSNEAGIGTAPMVHGASKNEEPVREG LIAMLGPFIDTIVVCTLTAMTIMVTGVWETGEKDGVLMTLSAFQSGIPVVGKYFLMAAVL VFALSTMFTYSYYGHKCFNYLFGADKANYYNYFYLLTIVGGAVVSLKVVMSFVDGMYAVM AFPTMISAIYLSPKVRAATKDYFRRMKEKNTL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server